‘Europeans must have access to portfolio of vaccines, including Sputnik-V’

Young journalists club

News ID: 50913
Publish Date: 10:01 - 07 March 2021
Solidarity among member states of the European Union should be about saving European lives by giving them access to a portfolio of vaccines, including the Russian-made Sputnik-V, the vaccine’s Twitter account said.

‘Europeans must have access to portfolio of vaccines, including Sputnik-V’The remarks were made in reaction to a French cabinet minister’s criticism of the European Union (EU) member states for showing interest in the Russian and Chinese COVID-19 vaccines instead of the ones developed by the US and the UK.

Speaking to French radio RTL on Friday, France’s European Affairs Minister Clement Beaune called on fellow member states not to use Russia’s Sputnik V and China’s Sinopharm vaccines unless they are approved by the bloc’s medicines regulator, warning of a risk to the bloc’s unity and public health.

“If they were to choose the Chinese and/or Russian vaccine, I think it would be quite serious,” Beaune said, adding, “It would pose a problem in terms of our solidarity, and it would pose a health risk problem, because the Russian vaccine is not yet authorized in Europe.”

In a tweet on Saturday, the official Twitter account of Sputnik-V vaccine addressed the French minister and said, “Dear Clement Beaune, EU solidarity should be about saving European lives by giving access to a portfolio of vaccines, including Sputnik V, already registered by 45 nations.”

“EU confirmed that EU countries have a right to order Sputnik V directly,” the tweet added.

Your Comment